Singapore markets closed

Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5842+0.0097 (+1.69%)
At close: 04:00PM EDT
0.6102 +0.03 (+4.45%)
After hours: 06:05PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.5745
Open0.5900
Bid0.5671 x 100
Ask0.6178 x 100
Day's range0.5501 - 0.6250
52-week range0.5300 - 7.2000
Volume176,491
Avg. volume554,766
Market cap4.431M
Beta (5Y monthly)0.76
PE ratio (TTM)N/A
EPS (TTM)-4.6900
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est11.33
  • Benzinga

    Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Why

    Ensysce Biosciences Inc (NASDAQ:ENSC) received an FDA Breakthrough Therapy Designation (BTD) for PF614-MPAR, a next-generation opioid. BTD has been granted to fewer than 300 drugs. It is designed to expedite the development and reviewing of drugs intended to treat a serious condition where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies. PF614-MPAR is designed to provide optimal pain relief at prescribed doses yet limit accid